Search Results - "Yu, Angela Y. C."

The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients by Walko, Christine M., Combest, Austin J., Spasojevic, Ivan, Yu, Angela Y. C., Bhushan, Shriya, Hull, J. Heyward, Hoskins, Janelle, Armstrong, Delma, Carey, Lisa, Collicio, Frances, Dees, E. Claire

“…Purpose The prodrug cyclophosphamide is metabolized by cytochrome P450(CYP)2B6 to the active metabolite, 4-hydroxycyclophosphamide (4-OH), and by CYP3A4/5 to…”
Get full text

Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancer by Zamboni, William C., Combest, Austin J., DeLoia, Julie A., Edwards, Robert P., Bridges, Arlene S., Zamboni, Beth A., Walko, Christine M., Yu, Angela Y. C., Krivak, Thomas C., Kelley, Joseph L.

“…Purpose The objectives of this study were to determine whether the midazolam clearance predicted docetaxel pharmacokinetics, CA-125 change, and response and to…”
Get full text